This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sunstar Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yuutarou Ogawa: Innovator in Peptide Research
Introduction
Yuutarou Ogawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of novel compounds with therapeutic potential. His work focuses on innovations that can impact health and medicine.
Latest Patents
Yuutarou Ogawa holds a patent for "Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof." This patent describes a novel peptide that exhibits ACE inhibitory activity, specifically a tripeptide consisting of Leu-Arg-Ala. This innovation has potential applications in the treatment of various health conditions.
Career Highlights
Ogawa is associated with Sunstar Inc., where he continues to advance his research in peptide technology. His work has garnered attention for its potential to improve health outcomes through innovative peptide applications.
Collaborations
Yuutarou Ogawa collaborates with notable colleagues, including Naohisa Shobako and Atsushi Ishikado. These partnerships enhance the research and development efforts within his field.
Conclusion
Yuutarou Ogawa is a key figure in peptide research, with a focus on developing innovative solutions for health-related challenges. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile